Solution structure ensemble of human obesity-associated protein FTO reveals druggable surface pockets at the

Balabhadra Khatiwada1, Trang T Nguyen1, Jeffrey A Purslow1

  • 1Department of Chemistry, Iowa State University, Ames, Iowa, USA.

Insights

The fat mass and obesity-associated (FTO) protein

Area of Science:

  • Biochemistry
  • Structural Biology
  • Epigenetics

Background:

  • The FTO protein regulates metabolic pathways via N6-methyladenosine demethylation.
  • FTO overexpression is linked to obesity and cancer, driving inhibitor development.
  • Existing FTO inhibitors often lack potency and selectivity.

Purpose of the Study:

  • To investigate the solution structure and dynamics of human FTO.
  • To identify potential targets for developing specific FTO inhibitors.

Main Methods:

  • Nuclear Magnetic Resonance (NMR) relaxation measurements.
  • Residual dipolar couplings analysis.
  • Accelerated molecular dynamics simulations.

Main Results:

  • The FTO N-terminal catalytic domain requires the C-terminal domain for stability and catalysis.
  • FTO exhibits conformational dynamics across multiple timescales at its domain interface and active site.
  • A conformational ensemble of apo FTO was generated, revealing transient pockets.

Conclusions:

  • The domain interaction is crucial for FTO structure and function.
  • Transient pockets at the domain interface are potential targets for allosteric inhibitors.
  • This study provides an atomic-resolution model of apo FTO dynamics.

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.9K
Protein-Protein Interfaces02:04

Protein-Protein Interfaces

3.9K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.6K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.1K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
106.5K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.0K